Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm

Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm

Background: Treatment of cardiovascular risk factors slows the progression of small abdominal aortic aneurysms (AAA). Heme oxygenase-1 (HO-1) is a stress- and hemin-induced enzyme providing cytoprotection against oxidative stress when overexpressed. However, nothing is known about the effects of car...

Full description

Bibliographic Details
Main Authors: Anja Hofmann, Bianca Hamann, Anna Klimova, Margarete Müglich, Steffen Wolk, Albert Busch, Frieda Frank, Pamela Sabarstinski, Marvin Kapalla, Josef Albin Nees, Coy Brunssen, David M. Poitz, Henning Morawietz, Christian Reeps
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Antioxidants
Subjects:
vascular biology
cardiovascular risk factors
pharmacotherapy
abdominal aortic aneurysm
heme oxygenase-1
Online Access:https://www.mdpi.com/2076-3921/11/9/1753

Internet

https://www.mdpi.com/2076-3921/11/9/1753

Similar Items